HLA-C and graft versus host disease: To overcome the constraints of xeno-GVHD, researchers went on to develop MHC knockout immunodeficient mice, like NOG-dKO or NOG-β2 m, IAβdKO mice, which demonstrate a reduced susceptibility to xeno-GVHD and extended experimental time frames (73, 74).